Table 1.

Selected single-agent studies with BCR inhibitors

Selected single-agent studies with BCR inhibitors

BTK indicates Bruton tyrosine kinase; CLL, chronic lymphocytic leukemia; NHL, non-Hodgkin lymphoma; MCL, mantle cell lymphoma; DLBCL, diffuse large B-cell lymphoma; ABC, activated B-cell; and GCB, germinal center B-cell.

Close Modal

or Create an Account

Close Modal
Close Modal